Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.
Michael Kors Holdings Limited (NYSE: KORS) shares moved up 17.27 percent on Tuesday with about 23 million shares traded. The stock had one of the biggest advances in the NYSE and hit a new 52-week high of $93.18 during intra-day trading. The company released third-quarter results for fiscal 2014 that blew past analyst expectations. Earnings per share increased 73.4% and revenue increased 59% year over year, driven by incredible comparable-store sales growth of 27.8%. This was the 31st consecutive quarter of comparable-store sales growth for the company.
Get more information on Michael Kors Holdings Limited and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/KORS
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) shares closed up 129.91 percent on Tuesday with about 5.5 million shares traded. The stock posted one of the biggest advances in the NASDAQ and had one of the biggest volume jumps. Furiex also hit a new 52-week high of $121.97 during intra-day trading. All came after the company released data that its drug treating a form of IBS that results in diarrhea passed its phase 3 trials, soundly beating a placebo at the higher dosing.
Get more information on Furiex Pharmaceuticals, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/FURX
Liquidmetal Technologies Inc. (OTCBB: LQMT) shares closed up 5.55 percent on Tuesday with about 2.2 million shares traded. The company had no significant news released to explain the little pop in share price. Liquidmetal Technologies, Inc., a materials technology company, designs, develops, and sells products and components from bulk amorphous alloys worldwide.
Get more information on Liquidmetal Technologies Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/LQMT
Cannabis Science, Inc. (OTC: CBIS) shares closed up 17.23 percent on Tuesday with a little over 50 million shares traded. The stock was one of the biggest gainers in the OTC marketplace and hit a new 52-week high of $0.22 during intra-day trading. The U.S. Congress and President Obama appear positioned to approve the first federal law to legalize hemp cultivation and advanced research on a federal level, creating unprecedented opportunities for the Company to pursue patient-based pharmaceutical solutions for patients.
Get more information on Cannabis Science, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/CBIS
Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.